GB201901871D0 - Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases - Google Patents

Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases

Info

Publication number
GB201901871D0
GB201901871D0 GBGB1901871.2A GB201901871A GB201901871D0 GB 201901871 D0 GB201901871 D0 GB 201901871D0 GB 201901871 A GB201901871 A GB 201901871A GB 201901871 D0 GB201901871 D0 GB 201901871D0
Authority
GB
United Kingdom
Prior art keywords
cannabidiol
derivatives
treatment
mitochondrial diseases
mitochondrial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1901871.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitat Autonoma de Barcelona UAB
Original Assignee
Universitat Autonoma de Barcelona UAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitat Autonoma de Barcelona UAB filed Critical Universitat Autonoma de Barcelona UAB
Priority to GBGB1901871.2A priority Critical patent/GB201901871D0/en
Publication of GB201901871D0 publication Critical patent/GB201901871D0/en
Ceased legal-status Critical Current

Links

GBGB1901871.2A 2019-02-11 2019-02-11 Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases Ceased GB201901871D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1901871.2A GB201901871D0 (en) 2019-02-11 2019-02-11 Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1901871.2A GB201901871D0 (en) 2019-02-11 2019-02-11 Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases

Publications (1)

Publication Number Publication Date
GB201901871D0 true GB201901871D0 (en) 2019-04-03

Family

ID=65998523

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1901871.2A Ceased GB201901871D0 (en) 2019-02-11 2019-02-11 Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases

Country Status (1)

Country Link
GB (1) GB201901871D0 (en)

Similar Documents

Publication Publication Date Title
EP3684353A4 (en) Topical formulations of cannabinoids and use thereof in the treatment of pain
HUE049237T2 (en) Compositions for use in methods for the treatment of wounds, disorders, and diseases of the skin
PL3577135T3 (en) A pharmaceutical composition for use in the treatment or prevention of c5-related diseases
IL289167A (en) 2h-indazole derivatives and their use in the treatment of disease
EP3583113A4 (en) Use of tgf alpha for the treatment of diseases and disorders
IL284125A (en) Quinoline derivatives for use in the treatment of inflammation diseases
EP3639833A4 (en) Agent for the prevention or treatment of fat-related diseases and/or inflammation
IL274578A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
IL286268A (en) Pridopidine for use in the treatment of mitochondrial associated diseases and disorders, including symptoms thereof
EP3302464A4 (en) Use of cannabinoids in the treatment of ocular inflammation and/or pain
HK1243327A1 (en) Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions
PT3937948T (en) Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases
IL272495A (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
EP3766503A4 (en) Application of microrna-210 inhibitor in the preparation of drugs for treating inflammatory skin diseases
HUE057646T2 (en) Tyrothricin for use in the treatment or prophylaxis of body odour and preparations therefor
PL3515409T3 (en) Complex and compositions for the treatment of ophthalmic and dermatological diseases
GB201901871D0 (en) Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases
PL3937949T3 (en) Phytoecdysones and the derivatives thereof for use in the treatment of impaired lung function
EP4017496A4 (en) Formulations for use in the prevention and/or treatment of peripheral neuropathy and its associated diseases
ZA201804198B (en) Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body
PL3813843T3 (en) Composition for use in the prevention and/or treatment of osteoarticular diseases
EP4025304C0 (en) Thioridazine derivatives and their use for the treatment of cancer
IL271592B1 (en) Compositions comprising an anti-inflammatory drug and a dicer activator for use in the treatment of neuronal diseases
GB201817346D0 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of diseases
GB201914886D0 (en) Medicine/Ailments and diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)